Cresanto Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve 1. Audited Financial Results ....
Awaiting price reaction for this filing.
Cresanto Global Ltd (formerly Raymed Labs Limited) has notified BSE that its Board meeting is scheduled for 28th May 2026. The meeting will consider and approve the audited financial results for the quarter and year ended 31st March 2026, and take on record the Auditor's Report. The company has closed its trading window from 1st April 2026 until 48 hours after results declaration on 30th May 2026. This is a standard regulatory intimation under SEBI LODR Regulation 29. No financial details or preliminary numbers are disclosed in this filing.
This is a routine filing announcing a board meeting. No material information is provided until results are actually declared. The trading window closure is standard practice and does not indicate any issues.